pra, whitepaper, human, liability, clinical trials

Download whitepaper: Risk-Based Monitoring for Late-Phase Research

The growing consensus among clinical researchers and regulatory authorities is that risk-based monitoring (RBM) is more likely to ensure patient protection and overall study quality, and allows for monitoring that can be more effective than the traditional model of routine visits to all sites with 100% source data verification (SDV). A number of factors are leading to the paradigm shift …